Back to search

Article

Pharmacokinetic recall study of Estonian Biobank participants carrying novel genetic variants in CYP2C19 and CYP2D6

2025-07-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: <italic>CYP2C19</italic> and <italic>CYP2D6</italic> collectively account for the hepatic metabolism of approximately 35–40% of clinically used drugs. Their genetic polymorphisms significantly influence drug response, including the risk of adverse drug reactions. However, the genetic basis for interindividual differences remains incompletely understood, with mis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37619ddf-25db-52ca-9819-61f2deaf3eb5
DOI
10.21203/rs.3.rs-7084648/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacokinetic recall study of Estonian Biobank participants carrying novel genetic variants in CYP2C19 and CYP2D6DOI 10.21203/rs.3.rs-7084648/v1
Select a neighboring publication to make it the new centre.